Acutaas Chemicals Limited (BOM:543349)

Market Cap	115.11B
Revenue (ttm)	10.37B
Net Income (ttm)	1.89B
Shares Out	n/a
EPS (ttm)	23.19
PE Ratio	60.88
Forward PE	46.44
Dividend	1.50 (0.11%)
Ex-Dividend Date	Sep 13, 2024

Volume	8,356
Average Volume	24,900
Open	1,438.85
Previous Close	1,423.20
Day's Range	1,396.05 - 1,438.85
52-Week Range	635.95 - 1,444.05
Beta	n/a
RSI	67.60
Earnings Date	Jul 28, 2025

About Acutaas Chemicals

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson’s, antidepressant, and anticoagulant applications, as well as in new chemical entities. It also provides specialty chemicals for use in agrochemicals, cosmetics, and polymers; and parabens and parabens formul...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2004
• Employees: 676
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 543349

Financial Performance

In 2024, Acutaas Chemicals's revenue was 10.07 billion, an increase of 40.34% compared to the previous year's 7.17 billion. Earnings were 1.59 billion, an increase of 271.06%.